Some of today’s large language models may be more effective communicators than providers when it comes to explaining interventional radiology procedures.
The U.S. Food and Drug Administration highlighted concerns about "data drift," which can potentially lead to performance degradation, bias or reduced reliability.
This uptick was attributed to more scans being administered per ED visit, rather than a rise in overall patient volumes, an analysis of Medicare data found.
New research analyzes the effectiveness of AI-generated reports in simplifying radiologists’ imaging interpretations into more easily understandable language, as judged by nonphysicians.
Drawing inspiration from the World War II “Why We Fight” campaign that rallied support for the U.S. war effort, AMA President Jesse Ehrenfeld, MD, spoke on the uphill battles physicians are facing today.
The Value Realization Pyramid is designed to help healthcare providers derive value from their technological investments by leveraging high-quality data. It emphasizes standardized data driving efficient workflows enterprise-wide. Executives are empowered to make data-driven decisions and can optimize operations and achieve strategic goals.
An updated version of Heartflow's Plaque Analysis platform has gained FDA clearance. In addition, the company announced that Cigna will cover the platform going forward.
Several groups collaborated on the document, which is designed to help clinicians provide high-quality, consistent care when using flurpiridaz during cardiac PET imaging exams.
